CN101785819A - Traditional Chinese medicine combination and preparation method thereof for hydrothorax treatment - Google Patents
Traditional Chinese medicine combination and preparation method thereof for hydrothorax treatment Download PDFInfo
- Publication number
- CN101785819A CN101785819A CN201010114592A CN201010114592A CN101785819A CN 101785819 A CN101785819 A CN 101785819A CN 201010114592 A CN201010114592 A CN 201010114592A CN 201010114592 A CN201010114592 A CN 201010114592A CN 101785819 A CN101785819 A CN 101785819A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- fructus
- radix
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a new traditional Chinese medicine combination and a preparation method thereof for hydrothorax treatment; the traditional Chinese medicine combination includes the following source medicines: cinnamon, pinellia ternate, ligusticum wallichii, storax, semen lepidii, pyrrosia lingua, rhizoma atractylodis, mangnolia officinalis, poria cocos, rhizoma acori graminei, ricepaperplant pith, notopterygium root, plantain seed, dried tangerine, immature bitter orange, cyperus rotundus, szechwan Chinaberry fruit, aspongopus, rhizoma sparganii, zedoary root, pangolin and angelica and the like. The traditional Chinese medicine combination can be prepared into any type of common oral preparation according to the conventional traditional Chinese medicine preparation method. The invention can significantly improve the symptoms of pleural effusion, hydrothorax, phlegmatic fluid, sputum, shortness of breath, palpitations, choking sensation in chest, expiratory dyspnea, doldrums, difficult breathing, and also has definite clinical curative effect, significant curative and quick effect. As the traditional Chinese medicine combination basically combines medicinal and edible medicine sources specified in the National Formulary, the traditional Chinese medicine combination has low cost and basically has no toxic and side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition for the treatment of hydrothorax.Relating in particular to a kind of is the Chinese medicine composition and preparation method thereof of the treatment hydrothorax of crude drug with the Chinese herbal medicine.
Background technology
Hydrothorax is meant by lung and pleural neoplasms or metastatic tumo(u)r, parasite, inflammation and causes etc. that hydrops appears in the pleural space that reason causes.General onset is more anxious, the violent chest pain of Ipsilateral appears in early days, as the acupuncture sample that lancinates, it is even more serious to deeply breathe or cough, and along with hydrops increases, tachypnea, cardiopalmus and dyspnea can appear in the patient, and increase the weight of gradually, part patient is also shown in heating, dry cough etc., the The Long-term Effect pulmonary function, and the clinical onset rate has the trend of continuous rising in recent years.
The local therapeutic approaches that modern medicine is taked breast to wear to take out hydrops, side effect is big, and easily recurrence, often fall flat, can not find suitable Therapeutic Method, in order to overcome above-mentioned defective, the present invention is based on the differential diagnosis of diseases and the dialectical principle that combines of Chinese traditional treatment hydrothorax, treating both the principal and secondary aspects of a disease, deficiency and excess is also controlled, inside and outside logical accent, emergency is taken in concurrently, filter out supplementing QI and nourishing YIN, dampness removing expectorant natural plant,, be prepared from according to certain weight proportion according to the theory of Chinese medical science prescription.A kind of Chinese medicine composition of evident in efficacy, with low cost, treatment hydrothorax that toxic and side effects is minimum is provided.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage forms, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be: pill, capsule, tablet, powder, granule or oral liquid etc.
Summary of the invention
Technical problem to be solved by this invention is assorted to overcome above-described shortcoming, and a kind of Chinese medicine composition of treatment hydrothorax of evident in efficacy, with low cost, almost non-toxic side effect is provided.
The technical problem of the desired solution of the present invention realizes by following technological approaches.
A kind of Chinese medicine composition for the treatment of hydrothorax of the present invention, the component of main following weight portion is formed:
1～100 part of Cortex Cinnamomi, 1～100 part of the Rhizoma Pinelliae, 1～100 part of Radix Et Rhizoma Rhei, 1～120 part of Lignum Dalbergiae Odoriferae, 1～50 part of Lignum Aquilariae Resinatum, 1～120 part of Styrax, 1～150 part of Semen Lepidii (Semen Descurainiae), 1～120 part of Rhizoma Chuanxiong, 1～150 part of Rhizoma Et Radix Notopterygii, 1～120 part of Radix Saposhnikoviae, 1～50 part of Herba Menthae, 1～150 part in Herba Spirodelae, 1～150 part of humus flava usta, 1～120 part of Spica Prunellae, 1～120 part of Radix Scutellariae, 1～100 part of Rhizoma Coptidis, 1～120 part of Cortex Fraxini, 1～120 part of Rhizoma Atractylodis, 1～120 part of Cortex Magnoliae Officinalis, 1～300 part in Poria, 1～120 part of Rhizoma Alismatis, 1～120 part of Exocarpium Benincasae, 1～120 part of Cortex Periplocae, 1～120 part of Semen Plantaginis, 1～120 part in Talcum, 1～120 part of 1～120 part of Herba Polygoni Avicularis of Medulla Tetrapanacis, 1～150 part of Spora Lygodii, 1～150 part of Rhizoma Acori Graminei, 1～100 part of Folium Pyrrosiae, 1～120 part of Fructus Evodiae, 1～50 part of Flos Caryophylli, 1～50 part of Fructus Foeniculi, 1～150 part of Pericarpium Citri Reticulatae, 1～150 part of Fructus Aurantii Immaturus, 1～150 part of Rhizoma Cyperi, 1～150 part of Fructus Toosendan, 1～60 part of Aspongopus.
Be preferably:
30 parts of Cortex Cinnamomis, 15 parts of the Rhizoma Pinelliaes, 20 parts of Radix Et Rhizoma Rhei, 30 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Styrax, 20 parts of Semen Lepidii (Semen Descurainiae)s, 30 parts of Rhizoma Chuanxiongs, 30 parts of Rhizoma Et Radix Notopterygiis, 40 parts of Radix Saposhnikoviaes, 10 parts of Herba Menthaes, 40 parts in Herba Spirodelae, 50 parts of humus flava ustas, 30 parts of Spica Prunellaes, 50 parts of Radix Scutellariaes, 20 parts of Rhizoma Coptidis, 30 parts of Cortex Fraxinis, 30 parts of Rhizoma Atractylodis, 50 parts of Cortex Magnoliae Officinalis, 150 parts in Poria, 30 parts of Rhizoma Alismatis, 40 parts of Exocarpium Benincasaes, 50 parts of Cortex Periplocaes, 60 parts of Semen Plantaginiss, 30 parts in Talcum, 30 parts of 40 parts of Herba Polygoni Avicularis of Medulla Tetrapanacis, 100 parts of Spora Lygodii, 50 parts of Rhizoma Acori Graminei, 30 parts of Folium Pyrrosiaes, 30 parts of Fructus Evodiaes, 15 parts of Flos Caryophyllis, 15 parts of Fructus Foeniculi, 60 parts of Pericarpium Citri Reticulataes, 100 parts of Fructus Aurantii Immaturuss, 120 parts of Rhizoma Cyperi, 100 parts of Fructus Toosendans, 20 parts of Aspongopuss.
The weight portion consumption of each component of Chinese medicine composition of the present invention can also be:
1～100 part of Fructus Amomi, 1～100 part of Fructus Tsaoko, 1～150 part in Fructus Hordei Germinatus, 1～150 part of Fructus Setariae Germinatus, 1～100 part of Endothelium Corneum Gigeriae Galli, 1～120 part of Radix Curcumae, 1～120 part of rhizoma sparganic, 1～120 part of Rhizoma Curcumae, 1～100 part of Squama Manis, 1～120 part of Radix Platycodonis, 1～150 part of Fructus Trichosanthis, 1～120 part of Succus Bambusae, 1～100 part of Fructus Rosae Laevigatae, 1～120 part of Semen Euryales, 1～100 part of Fructus Ligustri Lucidi, 1～150 part of Radix Astragali, 1～100 part of Radix Codonopsis, 1～150 part of Radix Angelicae Sinensis, 1～150 part of the Rhizoma Atractylodis Macrocephalae, 1～150 part of Rhizoma Dioscoreae.
Be preferably:
15 parts of Fructus Amomis, 15 parts of Fructus Tsaokos, 50 parts in Fructus Hordei Germinatus, 50 parts of Fructus Setariae Germinatuss, 30 parts of Endothelium Corneum Gigeriae Galli, 40 parts of Radix Curcumaes, 30 parts of rhizoma sparganic, 30 parts of Rhizoma Curcumae, 10 parts of Squama Maniss, 20 parts of Radix Platycodoniss, 60 parts of Fructus Trichosanthis, 30 parts of Succus Bambusaes, 30 parts of Fructus Rosae Laevigatae, 40 parts of Semen Euryaless, 30 parts of Fructus Ligustri Lucidi, 50 parts of Radix Astragali, 30 parts of Radix Codonopsis, 60 parts of Radix Angelicae Sinensis, 50 parts of the Rhizoma Atractylodis Macrocephalaes, 100 parts of Rhizoma Dioscoreaes.
Above-mentioned Chinese medicine composition of the present invention adds various conventional adjuvant required when preparing different dosage form, for example disintegrating agent, lubricant, adhesive etc. are prepared into any oral formulations commonly used with the method for Chinese medicinal of routine, for example can be pill, capsule, tablet, powder, granule or oral liquid etc.
Chinese medicine composition of the present invention is opened one's minds based on traditional Chinese medical science the five internal organs differentiation of syndromes of YIN and YANG guiding principle, in conjunction with safe one and Pu innovation theory system " ten thousand diseases ascent theory ", " the five internal organs differentiation of syndromes of YIN and YANG guiding principle ", " three-dimensional conservation regulation and control rule " and clinical treatment " pairing principle " are as instructing, take place in conjunction with disease, development and the rule that changes, classify according to the original new drug system, formation is monarch with " the five internal organs basic function is adjusted; equilibrium between yin and yang coordination side ", " the main pathogenesis of the five internal organs adjustment side " is minister, " therapy of serious disease side " is assistant, " clinical fundamental symptoms symptomatic treatment side " Chinese medicine patent medicine " original new drug system " for making.
The used herbal raw material medicine of the present invention all can be buied from the Chinese medicine shop, and its specification meets national medical standard.
Usage and dosage: dosage of the present invention depends on concrete dosage form, factors such as patient age, body weight, health status.As guidance: for oral administration: 1) capsule: obey 2～5 every day three times at every turn, every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 3～5 grams, warm water takes.4) granule: every day three times.Each 3～5 grams, warm water takes.5) powder: every day three times, each 2～4 grams, warm water takes.
The treatment that the present invention is directed to the hydrothorax patient is very effective, various crude drug are coordinated mutually can play together and are at utmost brought into play drug effect, can effectively improve the self-coordination ability of patient's body, significantly improve function and clinical subjective symptoms, have advantage such as have no side effect, expense is lower in addition.
The specific embodiment
Further describe the present invention by the following examples, it should be understood that these embodiment only are used for the purpose of illustration, never are limited to the present invention.
The preparation of [embodiment 1] capsule
Take by weighing each raw material by following weight portion: 30 parts of Cortex Cinnamomis, 15 parts of the Rhizoma Pinelliaes, 20 parts of Radix Et Rhizoma Rhei, 30 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Styrax, 20 parts of Semen Lepidii (Semen Descurainiae)s, 30 parts of Rhizoma Chuanxiongs, 30 parts of Rhizoma Et Radix Notopterygiis, 40 parts of Radix Saposhnikoviaes, 40 parts in Herba Spirodelae, 50 parts of Radix Scutellariaes, 20 parts of Rhizoma Coptidis, 30 parts of Cortex Fraxinis, 30 parts of Rhizoma Atractylodis, 50 parts of Cortex Magnoliae Officinalis, 150 parts in Poria, 30 parts of Rhizoma Alismatis, 60 parts of Semen Plantaginiss, 30 parts in Talcum, 100 parts of Spora Lygodii, 50 parts of Rhizoma Acori Graminei, 30 parts of Folium Pyrrosiaes, 60 parts of Pericarpium Citri Reticulataes, 100 parts of Fructus Aurantii Immaturuss, 120 parts of Rhizoma Cyperi, 100 parts of Fructus Toosendans, 20 parts of Aspongopuss, 15 parts of Fructus Amomis, 15 parts of Fructus Tsaokos, 50 parts in Fructus Hordei Germinatus, 50 parts of Fructus Setariae Germinatuss, 30 parts of Endothelium Corneum Gigeriae Galli, 40 parts of Radix Curcumaes, 30 parts of rhizoma sparganic, 30 parts of Rhizoma Curcumae, 10 parts of Squama Maniss, 60 parts of Radix Angelicae Sinensis, 50 parts of the Rhizoma Atractylodis Macrocephalaes.
Grind into after each component mixing with above-mentioned weight and incapsulate promptly after fine powder is crossed 1500 mesh sieves.
The preparation of [embodiment 2] granule
Take by weighing each raw material by following weight portion: 30 parts of Cortex Cinnamomis, 15 parts of the Rhizoma Pinelliaes, 20 parts of Radix Et Rhizoma Rhei, 30 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Styrax, 20 parts of Semen Lepidii (Semen Descurainiae)s, 30 parts of Rhizoma Chuanxiongs, 30 parts of Rhizoma Et Radix Notopterygiis, 40 parts of Radix Saposhnikoviaes, 40 parts in Herba Spirodelae, 50 parts of Radix Scutellariaes, 20 parts of Rhizoma Coptidis, 30 parts of Cortex Fraxinis, 30 parts of Rhizoma Atractylodis, 50 parts of Cortex Magnoliae Officinalis, 150 parts in Poria, 30 parts of Rhizoma Alismatis, 60 parts of Semen Plantaginiss, 30 parts in Talcum, 100 parts of Spora Lygodii, 50 parts of Rhizoma Acori Graminei, 30 parts of Folium Pyrrosiaes, 60 parts of Pericarpium Citri Reticulataes, 100 parts of Fructus Aurantii Immaturuss, 120 parts of Rhizoma Cyperi, 100 parts of Fructus Toosendans, 20 parts of Aspongopuss, 15 parts of Fructus Amomis, 15 parts of Fructus Tsaokos, 50 parts in Fructus Hordei Germinatus, 50 parts of Fructus Setariae Germinatuss, 30 parts of Endothelium Corneum Gigeriae Galli, 40 parts of Radix Curcumaes, 30 parts of rhizoma sparganic, 30 parts of Rhizoma Curcumae, 10 parts of Squama Maniss, 60 parts of Radix Angelicae Sinensis, 50 parts of the Rhizoma Atractylodis Macrocephalaes.
Each raw material of above-mentioned weight fraction is mixed, after grinding into fine powder and crossing 1500 mesh sieves, add ethanol and make adhesive, add starch and do filler, be pressed into granule.
The preparation of [embodiment 3] tablet
Take by weighing each raw material according to following weight portion: 30 parts of Cortex Cinnamomis, 15 parts of the Rhizoma Pinelliaes, 20 parts of Radix Et Rhizoma Rhei, 30 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Styrax, 20 parts of Semen Lepidii (Semen Descurainiae)s, 30 parts of Rhizoma Chuanxiongs, 30 parts of Rhizoma Et Radix Notopterygiis, 40 parts of Radix Saposhnikoviaes, 40 parts in Herba Spirodelae, 50 parts of Radix Scutellariaes, 20 parts of Rhizoma Coptidis, 30 parts of Cortex Fraxinis, 30 parts of Rhizoma Atractylodis, 50 parts of Cortex Magnoliae Officinalis, 150 parts in Poria, 30 parts of Rhizoma Alismatis, 60 parts of Semen Plantaginiss, 30 parts in Talcum, 100 parts of Spora Lygodii, 50 parts of Rhizoma Acori Graminei, 30 parts of Folium Pyrrosiaes, 60 parts of Pericarpium Citri Reticulataes, 100 parts of Fructus Aurantii Immaturuss, 120 parts of Rhizoma Cyperi, 100 parts of Fructus Toosendans, 20 parts of Aspongopuss, 15 parts of Fructus Amomis, 15 parts of Fructus Tsaokos, 50 parts in Fructus Hordei Germinatus, 50 parts of Fructus Setariae Germinatuss, 30 parts of Endothelium Corneum Gigeriae Galli, 40 parts of Radix Curcumaes, 30 parts of rhizoma sparganic, 30 parts of Rhizoma Curcumae, 10 parts of Squama Maniss, 60 parts of Radix Angelicae Sinensis, 50 parts of the Rhizoma Atractylodis Macrocephalaes.
Each raw material of above-mentioned weight portion is mixed, after grinding into fine powder and crossing 800～1200 order dusting covers, make tablet promptly.
The preparation of [embodiment 4] pill
Take by weighing each raw material according to following weight portion: 30 parts of Cortex Cinnamomis, 15 parts of the Rhizoma Pinelliaes, 20 parts of Radix Et Rhizoma Rhei, 30 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Styrax, 20 parts of Semen Lepidii (Semen Descurainiae)s, 30 parts of Rhizoma Chuanxiongs, 30 parts of Rhizoma Et Radix Notopterygiis, 40 parts of Radix Saposhnikoviaes, 40 parts in Herba Spirodelae, 50 parts of Radix Scutellariaes, 20 parts of Rhizoma Coptidis, 30 parts of Cortex Fraxinis, 30 parts of Rhizoma Atractylodis, 50 parts of Cortex Magnoliae Officinalis, 150 parts in Poria, 30 parts of Rhizoma Alismatis, 60 parts of Semen Plantaginiss, 30 parts in Talcum, 100 parts of Spora Lygodii, 50 parts of Rhizoma Acori Graminei, 30 parts of Folium Pyrrosiaes, 60 parts of Pericarpium Citri Reticulataes, 100 parts of Fructus Aurantii Immaturuss, 120 parts of Rhizoma Cyperi, 100 parts of Fructus Toosendans, 20 parts of Aspongopuss, 15 parts of Fructus Amomis, 15 parts of Fructus Tsaokos, 50 parts in Fructus Hordei Germinatus, 50 parts of Fructus Setariae Germinatuss, 30 parts of Endothelium Corneum Gigeriae Galli, 40 parts of Radix Curcumaes, 30 parts of rhizoma sparganic, 30 parts of Rhizoma Curcumae, 10 parts of Squama Maniss, 60 parts of Radix Angelicae Sinensis, 50 parts of the Rhizoma Atractylodis Macrocephalaes.
Each raw material of above-mentioned weight is mixed, grind into cross 600～1000 mesh sieves behind the fine powder after, make pill promptly.
The preparation of [embodiment 5] oral liquid
Take by weighing each raw material according to following weight portion: 30 parts of Cortex Cinnamomis, 15 parts of the Rhizoma Pinelliaes, 20 parts of Radix Et Rhizoma Rhei, 30 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Styrax, 20 parts of Semen Lepidii (Semen Descurainiae)s, 30 parts of Rhizoma Chuanxiongs, 30 parts of Rhizoma Et Radix Notopterygiis, 40 parts of Radix Saposhnikoviaes, 40 parts in Herba Spirodelae, 50 parts of Radix Scutellariaes, 20 parts of Rhizoma Coptidis, 30 parts of Cortex Fraxinis, 30 parts of Rhizoma Atractylodis, 50 parts of Cortex Magnoliae Officinalis, 150 parts in Poria, 30 parts of Rhizoma Alismatis, 60 parts of Semen Plantaginiss, 30 parts in Talcum, 100 parts of Spora Lygodii, 50 parts of Rhizoma Acori Graminei, 30 parts of Folium Pyrrosiaes, 60 parts of Pericarpium Citri Reticulataes, 100 parts of Fructus Aurantii Immaturuss, 120 parts of Rhizoma Cyperi, 100 parts of Fructus Toosendans, 20 parts of Aspongopuss, 15 parts of Fructus Amomis, 15 parts of Fructus Tsaokos, 50 parts in Fructus Hordei Germinatus, 50 parts of Fructus Setariae Germinatuss, 30 parts of Endothelium Corneum Gigeriae Galli, 40 parts of Radix Curcumaes, 30 parts of rhizoma sparganic, 30 parts of Rhizoma Curcumae, 10 parts of Squama Maniss, 60 parts of Radix Angelicae Sinensis, 50 parts of the Rhizoma Atractylodis Macrocephalaes.
Each raw material of above-mentioned weight is mixed, after three decoctions, three filtrates are mixed, filter, be concentrated into rule
Fixed concentration, put cold, the stock solution embedding, irradiation sterilization, after the check, packed products is made oral liquid promptly.
[experimental example] traditional Chinese medicine composition for treating hydrothorax of the present invention patient's clinical observation on the therapeutic effect experiment
One, the physical data of experimental subject: adopt Chinese medicine composition of the present invention to treat 59 routine patients altogether, wherein male 31 examples, women 28 examples; The oldest person 79 years old, the age reckling has only 16 years old.
Two, Therapeutic Method:
Usage and dosage: adopt the prepared medicament of the embodiment of the invention, its usage and consumption are as follows: 1) capsule: obey 2～5 every day three times at every turn, and every content of dispersion 0.4 gram, warm water takes.2) tablet: every day three times, each 2～4, every content of dispersion 0.5 gram, warm water takes.3) pill: every day three times, each 3～5 grams, warm water takes.4) granule: every day three times.Each 3～5 grams, warm water takes.5) powder: every day three times, each 2～4 grams, warm water takes.
The course of treatment: one month is a course of treatment, treats for 3 courses of treatment altogether.
Three, therapeutic evaluation standard
Cure: hydrothorax disappears, and symptom is improved fully, and is happy, in high spirits.
Produce effects: hydrothorax disappears substantially, and symptom is improved substantially, and mood is comparatively happy, and spirit better.
Effectively: hydrothorax is obviously less, breathes normally substantially, and mood is better, and spirit is improved.
Invalid: hydrothorax does not have and subtracts or increase, and sign does not have any change, symptom such as preceding.
Four, model case:
1, clock so-and-so, woman, 42 years old, teacher.
Main suit: dyspnea first quarter moon.The right side chest pain can not be put down for sleeping in.X line rabat: hydrothorax is rib before right side second.Chemical examination: ESR78mm/h, tuberculosis antibody (+).Diagnosis: tuberculous pleuritis hydrothorax.After the hydrothorax treatment was extracted in twice puncture of patients undergo, the further consultation hydrothorax was still to the second preceding rib.
Took Chinese medicine composition of the present invention 3, the right side chest pain alleviates, and dyspnea is alleviated, X line rabat: hydrothorax is more preceding to absorb chemical examination: ESR56mm/h, tuberculosis antibody (+) to some extent.The clothes Chinese medicine composition of the present invention 15 days that continues, chest pain is greatly alleviated, and breathes more smooth and easyly, can put down for sleeping inly, and X line rabat: the more preceding continuation of hydrothorax reduces, and chemically examines: ESR32mm/h, tuberculosis antibody (+).Obeyed Chinese medicine composition of the present invention 35, chest pain disappears, and breathes smooth and easyly, and X line rabat: hydrothorax all absorbs, and chemically examines: ESR17mm/h, and tuberculosis antibody (+), symptom is greatly taken on a new look.Continue and obeyed Chinese medicine composition of the present invention 1 month, all normal, follow up a case by regular visits to not recurrence in 3 years.
2, thank certain, man, 49 years old, workman.
Sky surplus the left side pulmonary carcinoma postoperative 7 months, companion's sputum mixed with blood ten out of breath uncomfortable in chest.Once chemotherapy 6 times after surgery, surplus in the of nearly ten day over, sensation of oppression over the chest with shortness of breath appears in the patient, expectoration, sputum mixed with blood, color is scarlet, is hard and dry.Ultrasound diagnosis is a large amount of hydrops in thoracic cavity, right side.Patient's emaciated physique, fatigue and weakness, diet is depressed, dimly red tongue, yellow and greasy fur, thready and rapid pulse.
Took Chinese medicine composition of the present invention 3, remission, ultrasound diagnosis: right pleural effusion before has absorption, continues and obeys Chinese medicine composition of the present invention 5, sensation of oppression over the chest with shortness of breath subtracts greatly, ultrasound diagnosis: the right pleural effusion amount is original 1/2, and appetite increases, and stool is normal, spirit is gradually shaken, obeyed Chinese medicine composition of the present invention 15, apoplexy due to phlegm is depletion of blood, ultrasound diagnosis: right pleural effusion disappears substantially.Continue and obeyed Chinese medicine composition of the present invention 1 month, symptom all disappears, weight increase.
3, Zhang, woman, 72 years old, retired cadre.
Main suit: right lung cancer postoperative 1 year, 3 months uncomfortable in chest out of breath.History of present illness: in the operation of the court's row right lung cancer, postoperative is because of the capable chemotherapy of physical weakness, and is out of breath uncomfortable in chest before 3 months before 1 year for the patient, examines through CT examination to be the right lung hydrothorax, and hospitalization does not have improvement.Patient's tired mind, the right lung diminished breath sound, body of the tongue is light red, tongue root Huang, preceding stripping, deep-thready pulse.
Take Chinese medicine composition of the present invention after 3 days, alleviation uncomfortable in chest out of breath, CT examination: the right lung hydrothorax before has absorption, the right lung respiratory murmur strengthens, and continues and obeys Chinese medicine composition of the present invention 5, and uncomfortable in chest the continuation alleviates, ultrasound diagnosis: the right pleural effusion amount is original 1/3, and spirit takes a turn for the better.Obeyed Chinese medicine composition of the present invention 15, disappearance uncomfortable in chest, ultrasound diagnosis: the more preceding continuation of right pleural effusion absorbs.Continue and obeyed Chinese medicine composition of the present invention 20, all diseases disappear entirely.
4, poplar, woman, 72 years old, peasant.
Suffer from tuberculous pleuritis before the JIUYUE, do not have obvious inducement, cardiopalmus, tachypnea 1 month increased the weight of for 1 week, night sweat, and chest pain is panted, and two pulmonary respiration sounds are low, arrhythmia, rabat, B ultrasonic all show hydrothorax.
Took Chinese medicine composition of the present invention 10, remission, B ultrasonic shows: hydrothorax before has absorption, and two pulmonary respiration sounds strengthen.The clothes Chinese medicine composition of the present invention 25 days that continues, tachypnea, chest pain are alleviated, cardiopalmus is gradually ended, ultrasound diagnosis: the right pleural effusion amount be original half, the spirit improvement was obeyed Chinese medicine composition of the present invention 15, disappearance uncomfortable in chest, ultrasound diagnosis: right pleural effusion disappears substantially.Continue and obeyed Chinese medicine composition of the present invention 30, all diseases are flat, and life is normal.
5, the week certain, woman, 18 years old.
The back appearance of suffering from cold before 2 weeks is generated heat, and body temperature fluctuates between " 38-39 ℃ ", has paroxysmal to cough repeatedly, and abundant expectoration is difficult for expectoration, companion's tachypnea is gone to a doctor in local hospital the chest B ultrasonic: the left side hydrothorax when coughing play, interior entrant sound is poor, antiinflammatory, the infusion treatment 4 days of reducing phlegm, and symptom does not have improvement.The infant tired mind, the face lip is pale.
Took Chinese medicine composition of the present invention 3, heating improves, 37.5 ℃ of body temperature, and cough alleviates, the easy expectoration of expectorant, B ultrasonic shows: the left side hydrothorax before has absorption, continues and obeys Chinese medicine composition of the present invention 5, body temperature is normal, ultrasound diagnosis: the more preceding remarkable minimizing of right pleural effusion amount, spiritual amelioration.Obeyed Chinese medicine composition of the present invention 45, ultrasound diagnosis: right pleural effusion disappears, and symptom all disappears.
6, Zhao, man, 39 years old, technician.
Occurred cough, expectoration before March, and engender and breathe hard activity postemphasis, the two lower limb pitting edemas of companion.C-XF shows two lung strip shadows down, bilateral pleural effusion.Breast CT is shown bilateral pleural effusion, right side interlobar effusion, multiple enlarged lymph node in the mediastinum.
Took Chinese medicine composition of the present invention 3, cough, expectoration symptom are significantly improved, and breast CT shows that bilateral pleural effusion before has absorption.Continue and obeyed Chinese medicine composition of the present invention 15, two lower limbs edema disappear, and breast CT is shown: the right side interlobar effusion all absorbs, spiritual amelioration.Obeyed Chinese medicine composition of the present invention 2 months, every inspection is all normal, and symptom all disappears, and follows up a case by regular visits to not recurrence in 3 years.
7, execute certain, man, 56 years old, engineer.
It is uncomfortable in chest that the patient played appearance in 2003, breathe hard, tussicula, become thin, in August, 2005 sx, the a large amount of hydrothorax in right side are found in the Chest X-rays of local hospital, hydrothorax is a yellow slurry, and invalid more than a year by the tuberculous pleuritis treatment, hydrothorax becomes courage and uprightness, repeatedly taking out hydrothorax, to look into oncocyte and tulase all negative, once more than 40 of intramuscular injection bleomycin A5 and invalid.
Took Chinese medicine composition of the present invention 5, uncomfortable in chest, breathing hard alleviates, symptom is significantly improved, ultrasound diagnosis: right pleural effusion before has absorption.Continue and obeyed Chinese medicine composition of the present invention 15, symptom further alleviates, and breast CT is shown: the more preceding remarkable minimizing of right pleural effusion.It is surplus February to obey Chinese medicine composition of the present invention, and ultrasound diagnosis: right pleural effusion all absorbs, and all diseases disappear entirely, and it is normal to follow up a case by regular visits to 3 years patients.8, Huang, man, 16 years old, student.
Right side low-back pain 8 months increased the weight of 1 month, no trauma history, and intermittent low-back pain can be alleviated after the rest, companion's night sweat, low grade fever, weak, uncomfortable in chest, tachypnea, chest pain.In local hospital row chest x-ray and CT examination, all find a large amount of hydrothorax in right side, respiratory movement weakens, and vocal fremitus weakens, and the lower field percussion is voiced sound, absent respiration in the right side.
Took Chinese medicine composition of the present invention 7, low grade fever ends, and all diseases alleviate, and breast CT is shown: the more preceding minimizing of right pleural effusion.Continue and obeyed Chinese medicine composition of the present invention 15, chest pain is ended, and uncomfortable in chest, tachypnea is significantly alleviated, and two lower limbs edema disappear, and breast CT is shown: the more preceding remarkable minimizing of right side hydrops, spiritual amelioration.Obey 1 first quarter moon of Chinese medicine composition of the present invention, above-mentioned symptom all disappears, and the patient lives study normally, follows up a case by regular visits to so far recurrence.
Five, therapeutic outcome:
In the 59 routine cases of being accepted for medical treatment,, wherein cure 25 examples through treatment in 3 months, produce effects 19 examples, effective 9 examples, invalid 6 examples, total effective rate reaches 89%.The result shows that Chinese medicine composition of the present invention has extremely significant curative effect to treatment hydrothorax patient.
Claims (7)
1. Chinese medicine composition for the treatment of hydrothorax is characterized in that: mainly contain following bulk drugs and form:
1～100 part of Cortex Cinnamomi, 1～100 part of the Rhizoma Pinelliae, 1～100 part of Radix Et Rhizoma Rhei, 1～120 part of Lignum Dalbergiae Odoriferae, 1～50 part of Lignum Aquilariae Resinatum, 1～120 part of Styrax, 1～150 part of Semen Lepidii (Semen Descurainiae), 1～120 part of Rhizoma Chuanxiong, 1～150 part of Rhizoma Et Radix Notopterygii, 1～120 part of Radix Saposhnikoviae, 1～50 part of Herba Menthae, 1～150 part in Herba Spirodelae, 1～150 part of humus flava usta, 1～120 part of Spica Prunellae, 1～120 part of Radix Scutellariae, 1～100 part of Rhizoma Coptidis, 1～120 part of Cortex Fraxini, 1～120 part of Rhizoma Atractylodis, 1～120 part of Cortex Magnoliae Officinalis, 1～300 part in Poria, 1～120 part of Rhizoma Alismatis, 1～120 part of Exocarpium Benincasae, 1～120 part of Cortex Periplocae, 1～120 part of Semen Plantaginis, 1～120 part in Talcum, 1～120 part of 1～120 part of Herba Polygoni Avicularis of Medulla Tetrapanacis, 1～150 part of Spora Lygodii, 1～150 part of Rhizoma Acori Graminei, 1～100 part of Folium Pyrrosiae, 1～120 part of Fructus Evodiae, 1～50 part of Flos Caryophylli, 1～50 part of Fructus Foeniculi, 1～150 part of Pericarpium Citri Reticulatae, 1～150 part of Fructus Aurantii Immaturus, 1～150 part of Rhizoma Cyperi, 1～150 part of Fructus Toosendan, 1～60 part of Aspongopus.
2. according to the described Chinese medicine composition of claim 1, it is characterized in that: the weight portion of each crude drug is:
30 parts of Cortex Cinnamomis, 15 parts of the Rhizoma Pinelliaes, 20 parts of Radix Et Rhizoma Rhei, 30 parts of Lignum Dalbergiae Odoriferaes, 10 parts of Lignum Aquilariae Resinatum, 20 parts of Styrax, 20 parts of Semen Lepidii (Semen Descurainiae)s, 30 parts of Rhizoma Chuanxiongs, 30 parts of Rhizoma Et Radix Notopterygiis, 40 parts of Radix Saposhnikoviaes, 10 parts of Herba Menthaes, 40 parts in Herba Spirodelae, 50 parts of humus flava ustas, 30 parts of Spica Prunellaes, 50 parts of Radix Scutellariaes, 20 parts of Rhizoma Coptidis, 30 parts of Cortex Fraxinis, 30 parts of Rhizoma Atractylodis, 50 parts of Cortex Magnoliae Officinalis, 150 parts in Poria, 30 parts of Rhizoma Alismatis, 40 parts of Exocarpium Benincasaes, 50 parts of Cortex Periplocaes, 60 parts of Semen Plantaginiss, 30 parts in Talcum, 30 parts of 40 parts of Herba Polygoni Avicularis of Medulla Tetrapanacis, 100 parts of Spora Lygodii, 50 parts of Rhizoma Acori Graminei, 30 parts of Folium Pyrrosiaes, 30 parts of Fructus Evodiaes, 15 parts of Flos Caryophyllis, 15 parts of Fructus Foeniculi, 60 parts of Pericarpium Citri Reticulataes, 100 parts of Fructus Aurantii Immaturuss, 120 parts of Rhizoma Cyperi, 100 parts of Fructus Toosendans, 20 parts of Aspongopuss.
3. according to the described Chinese medicine composition of claim 1, wherein crude drug also has:
1～100 part of Fructus Amomi, 1～100 part of Fructus Tsaoko, 1～150 part in Fructus Hordei Germinatus, 1～150 part of Fructus Setariae Germinatus, 1～100 part of Endothelium Corneum Gigeriae Galli, 1～120 part of Radix Curcumae, 1～120 part of rhizoma sparganic, 1～120 part of Rhizoma Curcumae, 1～100 part of Squama Manis, 1～120 part of Radix Platycodonis, 1～150 part of Fructus Trichosanthis, 1～120 part of Succus Bambusae, 1～100 part of Fructus Rosae Laevigatae, 1～120 part of Semen Euryales, 1～100 part of Fructus Ligustri Lucidi, 1～150 part of Radix Astragali, 1～100 part of Radix Codonopsis, 1～150 part of Radix Angelicae Sinensis, 1～150 part of the Rhizoma Atractylodis Macrocephalae, 1～150 part of Rhizoma Dioscoreae.
4. according to the described Chinese medicine composition of claim 3, wherein the weight portion of each component is:
15 parts of Fructus Amomis, 15 parts of Fructus Tsaokos, 50 parts in Fructus Hordei Germinatus, 50 parts of Fructus Setariae Germinatuss, 30 parts of Endothelium Corneum Gigeriae Galli, 40 parts of Radix Curcumaes, 30 parts of rhizoma sparganic, 30 parts of Rhizoma Curcumae, 10 parts of Squama Maniss, 20 parts of Radix Platycodoniss, 60 parts of Fructus Trichosanthis, 30 parts of Succus Bambusaes, 30 parts of Fructus Rosae Laevigatae, 40 parts of Semen Euryaless, 30 parts of Fructus Ligustri Lucidi, 50 parts of Radix Astragali, 30 parts of Radix Codonopsis, 60 parts of Radix Angelicae Sinensis, 50 parts of the Rhizoma Atractylodis Macrocephalaes, 100 parts of Rhizoma Dioscoreaes.
5. according to claim 1,2,3 or 4 described any Chinese medicine compositions, it is characterized in that: can be prepared into any oral formulations commonly used according to the method for Chinese medicinal of routine.
6. according to the described Chinese medicine composition of claim 5, it is characterized in that: described oral formulations is pill, capsule, tablet, powder, granule or oral liquid.
7. the application of the described any Chinese medicine composition of claim 1～6 in preparation treatment hydrothorax medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101145921A CN101785819B (en) | 2010-02-26 | 2010-02-26 | Traditional Chinese medicine combination and preparation method thereof for hydrothorax treatment |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010101145921A CN101785819B (en) | 2010-02-26 | 2010-02-26 | Traditional Chinese medicine combination and preparation method thereof for hydrothorax treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101785819A true CN101785819A (en) | 2010-07-28 |
| CN101785819B CN101785819B (en) | 2011-09-14 |
Family
ID=42529292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010101145921A Expired - Fee Related CN101785819B (en) | 2010-02-26 | 2010-02-26 | Traditional Chinese medicine combination and preparation method thereof for hydrothorax treatment |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101785819B (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101940708A (en) * | 2010-09-14 | 2011-01-12 | 曹锋 | Traditional Chinese medicinal preparation for curing malignant pleural effusion |
| CN102078571A (en) * | 2011-02-15 | 2011-06-01 | 冯安华 | Drug for treating early cirrhosis ascites |
| CN102614376A (en) * | 2012-04-09 | 2012-08-01 | 孙毅 | Traditional Chinese medical decoction for treatment of tuberculous pleural effusion |
| CN103638433A (en) * | 2013-12-02 | 2014-03-19 | 刘萍 | Pure traditional Chinese medicine composition for treating pleurisy |
| CN103704412A (en) * | 2013-12-31 | 2014-04-09 | 孙晓兵 | Milk tea electuary for curing pleural effusion conjunctivitis |
| CN103861017A (en) * | 2014-04-11 | 2014-06-18 | 胡海波 | Traditional Chinese medicinal composition for treating tuberculous pleural effusion and preparation method of composition |
| CN104587278A (en) * | 2015-02-15 | 2015-05-06 | 谢燕 | Traditional Chinese medicinal composition for treating pleural effusion and preparation method |
| CN104606563A (en) * | 2015-02-15 | 2015-05-13 | 谢燕 | Drug for treating pleural effusion and preparation method for drug |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496851A (en) * | 2008-01-28 | 2009-08-05 | 孙维刚 | Chinese medicine for treating carcinous pleural fluid and ascites |
-
2010
- 2010-02-26 CN CN2010101145921A patent/CN101785819B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101496851A (en) * | 2008-01-28 | 2009-08-05 | 孙维刚 | Chinese medicine for treating carcinous pleural fluid and ascites |
Non-Patent Citations (1)
| Title |
|---|
| 《辽宁中医学院学报》 20050930 梁国权 温阳利水法治疗胸积液10例 488 1-7 第7卷, 第5期 2 * |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101940708A (en) * | 2010-09-14 | 2011-01-12 | 曹锋 | Traditional Chinese medicinal preparation for curing malignant pleural effusion |
| CN102078571A (en) * | 2011-02-15 | 2011-06-01 | 冯安华 | Drug for treating early cirrhosis ascites |
| CN102614376A (en) * | 2012-04-09 | 2012-08-01 | 孙毅 | Traditional Chinese medical decoction for treatment of tuberculous pleural effusion |
| CN103638433A (en) * | 2013-12-02 | 2014-03-19 | 刘萍 | Pure traditional Chinese medicine composition for treating pleurisy |
| CN103638433B (en) * | 2013-12-02 | 2016-03-02 | 刘萍 | One treats pleuritic pure Chinese medicine composition |
| CN103704412A (en) * | 2013-12-31 | 2014-04-09 | 孙晓兵 | Milk tea electuary for curing pleural effusion conjunctivitis |
| CN103861017A (en) * | 2014-04-11 | 2014-06-18 | 胡海波 | Traditional Chinese medicinal composition for treating tuberculous pleural effusion and preparation method of composition |
| CN103861017B (en) * | 2014-04-11 | 2016-05-25 | 刘梅 | Be used for the treatment of Chinese medicine composition of tuberculous pleural effusion and preparation method thereof |
| CN104587278A (en) * | 2015-02-15 | 2015-05-06 | 谢燕 | Traditional Chinese medicinal composition for treating pleural effusion and preparation method |
| CN104606563A (en) * | 2015-02-15 | 2015-05-13 | 谢燕 | Drug for treating pleural effusion and preparation method for drug |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101785819B (en) | 2011-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101780237B (en) | Traditional Chinese medicine composition for treating cough and preparation method thereof | |
| CN101766804B (en) | Chinese herbal composite for epistaxis treatment and preparation method thereof | |
| CN101766790B (en) | Chinese medicine composite for treating chronic atrophic gastritis and preparation method thereof | |
| CN101785819B (en) | Traditional Chinese medicine combination and preparation method thereof for hydrothorax treatment | |
| CN101693099B (en) | Traditional Chinese medicine composite for treating tachyrhythmia and its preparation method | |
| CN101766802B (en) | Chinese medicine composite for treatment of acute gastroenteritis and preparation method thereof | |
| CN101822806B (en) | Traditional Chinese medicine composition for treating lung cancer and preparation method thereof | |
| CN101856459B (en) | Chinese medicinal composition for treating lung carbunculosis and preparation method thereof | |
| CN101785845B (en) | Traditional Chinese medicine combination and preparation method for intestinal flatulence treatment | |
| CN101766791A (en) | Chinese herbal composite for fever treatment and preparation method thereof | |
| CN101693089B (en) | Traditional Chinese medicine compound for treating diseases of lung Qi obstruction and dyspnea chest discomfort and preparation method thereof | |
| CN101829293A (en) | Traditional Chinese medicine composite for treating cough disease and preparation method thereof | |
| CN101716322A (en) | Traditional Chinese medicine composition for treating heart-blood deficiency disease and preparation method thereof | |
| CN101804172A (en) | Traditional Chinese medicine composition for treating anorexia and preparation method thereof | |
| CN101773622A (en) | Chinese medicinal composition for treating night sweats and preparation method thereof | |
| CN101829294B (en) | Traditional Chinese medicine composite for treating pyretic pulmonary disease and preparation method thereof | |
| CN101773634A (en) | Chinese medicine composition for treating abdominal distention and fullness and preparation method thereof | |
| CN101829296B (en) | Traditional Chinese medicine combination for treating pulmonary atelectasis and preparation method thereof | |
| CN101972432B (en) | Chinese medicinal composition for treating diarrhea associated with menstruation and preparation method thereof | |
| CN101829267B (en) | Traditional Chinese medicine combination for treating lung asthma and preparation method thereof | |
| CN101966319A (en) | Traditional Chinese medicinal composition for treating dizziness during menstruation and preparation method thereof | |
| CN101874879A (en) | Chinese medicinal composition for treating osteopyrexia and preparation method thereof | |
| CN101837112B (en) | Chinese medicinal composition for curing irregular menstrual period and preparation method thereof | |
| CN101816772B (en) | Chinese medicament for treating globus hystericuss and preparation method thereof | |
| CN101822814A (en) | Traditional Chinese medicine composition for treating lung failure and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110914 Termination date: 20130226 |